ARCHIVED - National Research Council Canada

• Previous Page
• Table of Contents
•  

This page has been archived.

Section III – Supplementary Information

3.1 Financial Highlights

The following general overview of NRC's financial position and operations are presented on an accrual basis for comparability with the complete financial statements published on NRC's Web site.

($ thousands)

Condensed Statement of Financial Position At End of Year (March 31, 2009)	% Change	2009	2008
Assets
Total Assets	(4 %)	821,313	851,212
Total	(4 %)	821,313	851,212
Liabilities
Total Liabilities	6 %	329,943	310,397
Equity
Total Equity	(9 %)	491,370	540,815
Total	(4 %)	821,313	851,212

($ thousands)

Condensed Statement of Operations At End of Year (March 31, 2009)	% Change	2009	2008
Expenses
Total Expenses	5 %	899,430	852,988
Revenues
Total Revenues	1 %	156,246	154,530
Net Cost of Operations	6 %	743,184	698,458

Revenues by Type

Revenue is important to NRC, not only as a means of financing its operating and capital expenditures, but also as an indication of the value that NRC provides to its clients and collaborators. NRC earned total revenues of $156 million in 2008-09, up slightly from $155 million earned in 2007-08. NRC's largest component of revenue results from the sale of goods and services, primarily consisting of research services provided to industry and academic clients ($66 million), with the remaining balance provided by the sale of goods and information products ($11.3 million), and NRC rights and privileges ($9.6 million).

[D]

Expenses by Type

NRC incurred total expenses of $899 million in 2008-09, up from $853 million in 2007-08. NRC's major expense components - salaries and employee future benefits ($463 million) and grants and contributions ($133 million) are most important to NRC representing 66% of total expenses. NRC's most significant cost driver, salaries and employee future benefits, accounts for the majority of the $46 million increase in total expenses. Salaries and employee future benefits increased to $463 million, representing 51% of total expenses.

[D]

3.2 List of Supplementary Information Tables

The following tables are located on the Treasury Board Secretariat Web site:

• Sources of Respendable and Non-Respendable Revenue
• User Fees
• Details on Transfer Payment Programs (TPPs)
• Horizontal Initiatives
• Green Procurement
• Response to Parliamentary Committees and External Audits
• Internal Audits and Evaluations

3.3 Other Items of Interest

NRC Council Members

NRC's Council provides strategic direction and advice to the President and monitors progress against strategic plans. The Minister of Industry can also consult the NRC Council for advice on matters affecting NRC and of importance to science and technology in Canada. It usually meets three times a year and has four standing committees: the Executive Committee, the Human Resources Committee and the Audit, Evaluation and Risk Assessment Committee, and the Finance Committee. The Council is chaired by the President of NRC and the other members are appointed by the Government of Canada for three-year terms. Current members are:

Pierre Coulombe,
President (and Chair of Council), National Research Council,
Ottawa, Ontario

Dennis Anderson,
Management Consultant,
Libau, Manitoba

Paul Clark,
Former Vice-President, Research and Technology, NOVA Chemicals Corporation,
Calgary, Alberta

Peter Frise,
Scientific Director and CEO, Auto 21, University of Windsor,
Windsor, Ontario

John Harker,
President, Cape Breton University,
Sydney, Nova Scotia

Margaret Lefebvre,
Executive Director, Canadian Association of Income Funds,
Montréal, Québec

Kellie Leitch,
Assistant Dean (External), Chief/Chair of Paediatric Surgery and Assistant Professor, Paediatric Orthopaedics, University of Western Ontario,
London, Ontario

Douglas MacArthur,
President, MacArthur Group, Inc.,
Charlottetown, Prince Edward Island

Eva Mah Borsato,
President, Intellectual Capital Corporation Inc.,
Edmonton, Alberta

Howard Tennant,
President Emeritus, University of Lethbridge,
Lethbridge, Alberta

Normand Tremblay,
Strategic Management Consultant, Normand Tremblay and Associates,
Montréal, Québec

Allan Warrack,
Professor of Business Emeritus, University of Alberta,
Edmonton, Alberta

David Wood,
Head of Finance and Corporate Development, Secretary and Treasurer, Celator Pharmaceuticals Inc.,
Vancouver, British Columbia

• Previous Page
• Table of Contents
•